TY - JOUR
T1 - Genetic Determinants Highlight the Existence of Shared Etiopathogenetic Mechanisms Characterizing Age-Related Macular Degeneration and Neurodegenerative Disorders
AU - Strafella, Claudia
AU - Caputo, Valerio
AU - Termine, Andrea
AU - Fabrizio, Carlo
AU - Ruffo, Paola
AU - Potenza, Saverio
AU - Cusumano, Andrea
AU - Ricci, Federico
AU - Caltagirone, Carlo
AU - Giardina, Emiliano
AU - Cascella, Raffaella
N1 - Funding Information:
This work was supported by Project MUSA CNR (FOE 2019).
Publisher Copyright:
© Copyright © 2021 Strafella, Caputo, Termine, Fabrizio, Ruffo, Potenza, Cusumano, Ricci, Caltagirone, Giardina and Cascella.
PY - 2021/5/31
Y1 - 2021/5/31
N2 - Age-related macular degeneration (AMD) showed several processes and risk factors in common with neurodegenerative disorders (NDDs). The present work explored the existence of genetic determinants associated with AMD, which may provide insightful clues concerning its relationship with NDDs and their possible application into the clinical practice. In this study, 400 AMD patients were subjected to the genotyping analysis of 120 genetic variants by OpenArray technology. As the reference group, 503 samples representative of the European general population were utilized. Statistical analysis revealed the association of 23 single-nucleotide polymorphisms (SNPs) with AMD risk. The analysis of epistatic effects revealed that ARMS2, IL6, APOE, and IL2RA could contribute to AMD and neurodegenerative processes by synergistic modulation of the expression of disease-relevant genes. In addition, the bioinformatic analysis of the associated miRNA variants highlighted miR-196a, miR-6796, miR-6499, miR-6810, miR-499, and miR-7854 as potential candidates for counteracting AMD and neurodegenerative processes. Finally, this work highlighted the existence of shared disease mechanisms (oxidative stress, immune-inflammatory response, mitochondrial dysfunction, axonal guidance pathway, and synaptogenesis) between AMD and NDDs and described the associated SNPs as candidate biomarkers for developing novel strategies for early diagnosis, monitoring, and treatment of such disorders in a progressive aging population.
AB - Age-related macular degeneration (AMD) showed several processes and risk factors in common with neurodegenerative disorders (NDDs). The present work explored the existence of genetic determinants associated with AMD, which may provide insightful clues concerning its relationship with NDDs and their possible application into the clinical practice. In this study, 400 AMD patients were subjected to the genotyping analysis of 120 genetic variants by OpenArray technology. As the reference group, 503 samples representative of the European general population were utilized. Statistical analysis revealed the association of 23 single-nucleotide polymorphisms (SNPs) with AMD risk. The analysis of epistatic effects revealed that ARMS2, IL6, APOE, and IL2RA could contribute to AMD and neurodegenerative processes by synergistic modulation of the expression of disease-relevant genes. In addition, the bioinformatic analysis of the associated miRNA variants highlighted miR-196a, miR-6796, miR-6499, miR-6810, miR-499, and miR-7854 as potential candidates for counteracting AMD and neurodegenerative processes. Finally, this work highlighted the existence of shared disease mechanisms (oxidative stress, immune-inflammatory response, mitochondrial dysfunction, axonal guidance pathway, and synaptogenesis) between AMD and NDDs and described the associated SNPs as candidate biomarkers for developing novel strategies for early diagnosis, monitoring, and treatment of such disorders in a progressive aging population.
KW - age-related macular degeneration
KW - etiopathogenesis
KW - genetic network
KW - miRNAs
KW - neurodegenerative disorders
KW - susceptibility
UR - http://www.scopus.com/inward/record.url?scp=85107835522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107835522&partnerID=8YFLogxK
U2 - 10.3389/fneur.2021.626066
DO - 10.3389/fneur.2021.626066
M3 - Article
AN - SCOPUS:85107835522
SN - 1664-2295
VL - 12
JO - Frontiers in Neurology
JF - Frontiers in Neurology
M1 - 626066
ER -